MedTrace Logo

Human Papillomavirus (HPV) Type Distribution in Adult Women Diagnosed With Invasive Cervical Cancer in New Zealand

NCT01328028 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 244

Last updated 2012-08-27

No results posted yet for this study

Summary

The aim of this study is to assess the distribution of the most frequent types of human papillomavirus in women diagnosed with invasive cervical cancer in New Zealand.

Conditions

Interventions

OTHER

Testing of archived cervical cancer tissue samples

Cervical samples will be tested for histopathology diagnosis and human papillomavirus deoxyribonucleic acid testing.

OTHER

Data collection

Log sheet

Sponsors & Collaborators

Principal Investigators

  • GSK Clinical Trials · GlaxoSmithKline

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-04-30
Primary Completion
2011-04-30
Completion
2011-04-30

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01328028 on ClinicalTrials.gov